NEGXF
NexgenRx Inc.·Healthcare
0.27
0.000%(+0.00)
Close PriceLast Updated: — ET
52W L: $0.1952W H: $0.28
NEGXF NEWS
accessnewswire.com
6d ago
NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth
TORONTO, ON / ACCESS Newswire / May 21, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2026, with net income of $1,228,288 and EBITDA of $1,444,036, representing increases of $701,078 and $615,635, respectively, compared to the same period in 2025.
accessnewswire.com
Apr 17
NexgenRx Announces Declaration of Divdend
TORONTO, ON / ACCESS Newswire / April 17, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common shares.
accessnewswire.com
Mar 31
NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth
TORONTO, ON / ACCESS Newswire / March 31, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2025, with net income and EBITDA improving to $3,350,704 (an increase of $1,011,282 as compared to 2024), net income increasing to $1,289,735 (an increase of $675,166 as compared to 2024) and revenues increasing by $1,457,136, to $14,933,914.
